Filters

EIF2C3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

EIF2C3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA) size: 1.0 µg DNA 322

Price 322
Size 1.0 µg DNA
DNA lentivector for transduction information GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetEIF2C3 Lentiviral Vector (CMV) (pLenti-GIII-CMV-C-term-HA)
Short nameEIF2C3 Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV-C-term-HA)
TechniqueVectors
Species Humans, Human
Alternative name sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus-c terminus-HA), EIF2C3 Lentiviral integrating Desoxyribonucleic acid sequence (H
Identity 18421
Gene AGO3
Long gene name RISC catalytic component , argonaute 3
Synonyms gene EIF2C3
Synonyms gene name 3 argonaute RISC catalytic component 3 , eukaryotic translation initiation factor 2C
Synonyms hAGO3 FLJ12765
Synonyms name argonaute 3
Locus 1p34, 3
Discovery year 2002-04-26
GenBank acession AB046787
Entrez gene record 192669
Pubmed identfication 12906857
RefSeq identity NM_024852
Classification Argonaute/PIWI family
Havana BLAST/BLAT OTTHUMG00000184172

Subscribe to our Newsletter